Novo Nordisk has welcomed Brian Hilberdink as President, Novo Nordisk Canada Inc.
Hilberdink is an accomplished executive with 20 years of global and domestic experience developing and executing Novo Nordisk's commercial strategy.
He was previously Vice President, Diabetes Marketing and Market Access, Novo Nordisk Canada. Prior to this, he was Corporate Vice President, Global Marketing, Novo Nordisk A/S, and led the commercialisation of the company's future insulin portfolio, from Phase II clinical development until the first launches in Europe and Japan.
Hilberdink also has experience working in the US where, as Director, Brand Management, he led multiple brand teams during a period of significant growth for Novo Nordisk US.
